Defective protein degradation in genetic disorders
Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are res...
Gespeichert in:
Veröffentlicht in: | Biochimica et biophysica acta. Molecular basis of disease 2022-05, Vol.1868 (5), p.166366-166366, Article 166366 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Understanding the molecular mechanisms that underlie different human pathologies is necessary to develop novel therapeutic strategies. An emerging mechanism of pathogenesis in many genetic disorders is the dysregulation of protein degradation, which leads to the accumulation of proteins that are responsible for the disease phenotype. Among the different cellular pathways that regulate active proteolysis, the Cullin RING E3 ligases represent an important group of sophisticated enzymatic complexes that mediate substrate ubiquitination through the interaction with specific adaptors. However, pathogenic variants in these adaptors affect the physiological ubiquitination of their substrates. This review discusses our current understanding of this emerging field.
•Many genetic disorders are caused by mutations in the ubiquitin-proteasome system.•Cullin RING E3 ubiquitin ligases (CRL) require adaptor proteins and substrate receptors.•CRL3 requires BTB proteins as substrate receptors.•Germline variants in genes encoding substrate receptors lead to different genetic conditions. |
---|---|
ISSN: | 0925-4439 1879-260X 1879-260X |
DOI: | 10.1016/j.bbadis.2022.166366 |